2024-03-18 13:40:03 ET
Intuitive Surgical, Inc. (ISRG)
da Vinci 5 Conference Call
March 18, 2024 08:45 ET
Company Participants
Gary Guthart - Chief Executive Officer
Dave Rosa - President
Myriam Curet - Chief Medical Officer
Jamie Samath - Chief Financial Officer
Conference Call Participants
Travis Steed - Bank of America
Larry Biegelsen - Wells Fargo
Robbie Marcus - JPMorgan
Rick Wise - Stifel
Adam Maeder - Piper Sandler
Brandon Vazquez - William Blair
Drew Ranieri - Morgan Stanley
Shagun Singh - RBC
Vijay Kumar - Evercore ISI
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Intuitive da Vinci 5 Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, CEO for Intuitive Surgical, Mr. Gary Guthart. Please go ahead.
Gary Guthart
Good morning and welcome to our call introducing Intuitive's fifth generation robotic system, da Vinci 5.
Before we begin, I'd like to inform you that the comments mentioned on today's call may be deemed to contain forward-looking statements. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in detail in our Securities and Exchange Commission filings, including our most recent Form 10-K filed on January 31, 2024. Our SEC filings can be found on our website or at SEC's website. Investors are cautioned not to place undue reliance on such forward-looking statements.
Joining me today are Dave Rosa, Intuitive's President; Dr. Myriam Curet, our Chief Medical Officer; and Jamie Samath, Chief Financial Officer. Today, we'll provide you with an overview of da Vinci 5, also described in our news release issued on Thursday, March 14. We plan to have da Vinci 5 at trade shows throughout the year, including the upcoming SAGES Conference in Cleveland, where attendees will have the opportunity to see da Vinci 5 and speak with our teams in person. Today's format will be as follows: Dave will take us through da Vinci 5's distinguishing features and how da Vinci 5 fits in our portfolio. Myriam will take us through our da Vinci 5 cleared indications and how we think about da Vinci 5's clinical and operational benefits for our customers and their patients. And Jamie will take you through how our launch plans for da Vinci 5 could impact our finances in 2024, followed by a question-and-answer session....
Read the full article on Seeking Alpha
For further details see:
Intuitive Surgical, Inc. (ISRG) da Vinci 5 Conference Call Transcript